Eurazeo
Eurazeo taps Rothschild for DORC exit
Upcoming process for Dutch medical equipment group expected to launch in September
Blackstone takes minority stake in Groupe Premium
Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn
Eurazeo co-CEOs seek to reassure market following key departures
Listed GP is also considering options for its stake in Spanish PE platform MCH, it said in its latest results
Eurazeo-backed DORC catches the eye of dealmakers with H2 process anticipated
Eurazeo acquired the Dutch ophthalmic surgical equipment producer for EUR 430m in 2019
Eurazeo halves deployment and PE fundraising in Q1 amid ‘complex and uncertain’ environment
GP has EUR 7.7bn dry powder across its strategies and remains assured of its potential to make exits in H2 2023
Eurazeo's Groupe Premium attracts multiple PE bidders ahead of IMs
Insurance broker has seen interest from parties including Ardian, Bridgepoint, BC Partners, Cinven, CVC
Eurazeo shakes up executive board; CEO Virginie Morgon to depart
New board members are chairmen Christophe Bavière and William Kadouch-Chassaing, as well as Sophie Flak and Olivier Millet
Going, going, not gone: PE auctions bid for relevance amid risk-off environment
With a debt financing drought and macro woes denting exits, GPs are adapting the traditional M&A auction in favour of more flexible bilateral negotiations to get deals across the line
Eurazeo, GA-backed Doctolib weighs growth financing options
Appointment booking platform is holding preliminary talks for its next growth milestone
Eurazeo takes majority stake in NeoXam following ‘intense process’
GP’s SME fund to invest over EUR 100m to become financial services software group’s largest shareholder
The Bolt-Ons Digest – 11 November 2022
Unquote’s selection of the latest add-ons including Hg and ICG's Iris, Inflexion's THE, Bain's House of HR and more
Eurazeo expects longer fundraising for flagship Fund V
EUR 3bn target to be partly funded by balance sheet; selective, resilient investments to attract LP's interest
The Bolt-Ons Digest – 16 September 2022
Unquote’s selection of the latest add-ons with A&M's Ayesa, BC Partners' Valtech, Advent's IRCA, EQT's IVC Evidensia and more
Eurazeo’s NAV dips amid volatile markets
Net asset value dips by 3.9% as French sponsor creates contingency buffer of EUR 500m to account for market uncertainty
Eurazeo PME IV holds 1bn close
Deployment has reached 40% for the new fund, with five to seven further platform investments penned
Eurazeo to reap 3.2x money multiple in Vitaprotech SBO to Apax
French GPs in exclusive negotiations for security specialist deal, which could generate IRR of 30%
Eurazeo reaps 3.7x money on Orolia exit to trade
Sale of majority stake in French precision electronics group generates EUR 189m in cash proceeds
Eurazeo in exclusivity for Sevetys acquisition
French sponsor beats Ardian and Antin in race for a majority stake in French veterinary chain
BC Partners, Ardian among sponsors in second round of Simago sale
Antin and Eurazeo also in race for minority stake in the French medical imaging specialist
Eurazeo heads for EUR 1bn H1 2022 close for PME IV
GP also said in its Q1 2022 results that it has EUR 4.7bn in dry powder across its strategies
Eurazeo gears up for Eurazeo Capital V
GP has registered the fund almost three years after the EUR 2.5bn final close of its predecessor
Bridgepoint in exclusivity to acquire G Square's Dentego
Mergermarket reported that sponsors including Ardian, BC, Eurazeo and IK showed interest in the asset
DiliTrust backed by Eurazeo, Cathay, Sagard Newgen in EUR 130m deal
Transaction will see Calcium Capital exit the French corporate governance services provider; Eurozeo to contribute with EUR 52m
Eurazeo PME to launch Redspher sale advised by Transaction R
Formerly known as Flash Europe, the French transportation business will be marketed off around EUR 20m EBITDA